Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Bladder dysfunction and quality of life for people with multiple sclerosis.
Altered transition metal homeostasis in the cuprizone model of demyelination.
Natural history of multiple sclerosis from the Indian perspective: Experience from a tertiary care hospital.
How do we manage and treat a patient with multiple sclerosis at risk of tuberculosis?
Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis.
Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity.
Recovery of peripheral muscle function from fatiguing exercise and daily physical activity level in patients with multiple sclerosis: A case-control study.
[Criteria of ineffectiveness of treatment with first-line therapy: how to use MRI results in decision making?]
Proceedings of the 6th Dubrovnik International Conference on Multiple Sclerosis, 10-12 May 2012, Dubrovnik, Croatia.
Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Quantitative magnetic resonance imaging of cortical multiple sclerosis pathology.
Quantitative Susceptibility Mapping of Multiple Sclerosis Lesions at Various Ages.
Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases.
What place for {blacktriangledown}cannabis extract in MS?
Quality of life in patients with multiple sclerosis in Republic of Srpska.
Generating induced pluripotent stem cells for multiple sclerosis therapy.
Effectiveness of telerehabilitation interventions in persons with multiple sclerosis: A systematic review.
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.
Cerebrospinal fluid ferritin-Unspecific and unsuitable for disease monitoring.
White matter disease: Longest follow-up of rituximab for neuromyelitis optica.
Developmentally regulated GTP-binding protein 2 ameliorates EAE by suppressing the development of TH17 cells.
Acquired Demyelinating and Other Autoimmune Disorders of the Central Nervous System in Children.
Reporting treatment outcomes in observational data: A fine balance.
Comparison of human adult stem cells from adipose tissue and bone marrow in the treatment of experimental autoimmune encephalomyelitis.
Nationwide Incidence of Acquired Central Nervous System Demyelination in Icelandic Children.

Pages